Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Is electronic monitoring of adherence to inhaled steroids useful in troublesome preschool wheeze?
  • +5
  • Yvonne Bingham,
  • James Cook,
  • Pippa Hall,
  • Angela Jamalzadeh,
  • Rachael Moore-Crouch,
  • Andrew Bush,
  • Louise Fleming,
  • Sejal Saglani
Yvonne Bingham
Imperial College London Faculty of Medicine - South Kensington Campus

Corresponding Author:[email protected]

Author Profile
James Cook
Imperial College London Faculty of Medicine - South Kensington Campus
Author Profile
Pippa Hall
Royal Brompton and Harefield NHS Foundation Trust
Author Profile
Angela Jamalzadeh
Royal Brompton and Harefield NHS Foundation Trust
Author Profile
Rachael Moore-Crouch
Royal Brompton and Harefield NHS Foundation Trust
Author Profile
Andrew Bush
Imperial College and Royal Brompton Hospital, London, UK
Author Profile
Louise Fleming
Imperial College and Royal Brompton Hospital, London, UK
Author Profile
Sejal Saglani
Imperial College London Faculty of Medicine - South Kensington Campus
Author Profile

Abstract

Background: Adherence to inhaled corticosteroids (ICS) is suboptimal in school-age children with asthma. Little is known about adherence to ICS in preschool children with troublesome wheeze. Children with aeroallergen sensitisation, or those with multiple trigger wheeze (MTW), should be differential ICS responders. We hypothesised that adherence to ICS and symptom control are only positively related in atopic children, or those with MTW. Methods: Patients aged 1-5 years with recurrent wheeze prescribed ICS were recruited from a tertiary respiratory clinic. Clinical phenotype and aeroallergen sensitisation were determined, and adherence assessed using an electronic monitoring device (Smartinhaler®). Symptom control (Test for Respiratory and Asthma Control in Kids (TRACK)), quality of life (PACQLQ), airway inflammation (offline exhaled nitric oxide (FeNO)) were assessed at baseline and follow-up. Results: Forty-eight children (mean age 3.7 years, SD 1.2) were monitored for a median of 112 (IQR 91-126) days. At baseline n=29 had episodic viral wheeze (EVW) and n= 19 had MTW. 24/48 (50%) wheezers had sub-optimal ICS adherence (<80%). Median adherence was 64% (IQR 38-84). There was a significant increase in TRACK in the group as a whole, unrelated to adherence. When split according to ICS responders, a significant increase in TRACK was only seen in atopic wheezers with adherence >60%. There was no relationship between clinical phenotype, adherence and symptom control. Conclusion: Adherence to ICS was sub-optimal and was positively related to symptom control in atopic wheezers only. Assessments of adherence are important in preschool children with an ICS responsive phenotype prior to therapy escalation.